Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000801289 | SCV000941060 | uncertain significance | Qualitative or quantitative defects of dysferlin | 2021-08-30 | criteria provided, single submitter | clinical testing | This sequence change replaces threonine with isoleucine at codon 602 of the DYSF protein (p.Thr602Ile). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and isoleucine. This variant is present in population databases (rs767805308, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with DYSF-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001825582 | SCV002079831 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-01-22 | no assertion criteria provided | clinical testing |